-2.5%
MS vs GSK
+1.7%
-4.2%
-21.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.9% | -1.4% | -4.5% | -5.9% |
| 7D | -3.4% | +3.6% | -6.9% | -3.4% |
| 30D | -3.9% | +8.2% | -12.1% | -3.9% |
| 3M | -15.9% | -1.2% | -14.8% | -15.4% |
| 6M | -2.5% | +1.9% | -4.4% | -2.2% |
| All | -2.5% | +1.7% | -4.2% | -2.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling